Psoralidin

Psoralidin is an agonist of Estrogen/Progesterone Receptors and Estrogen Receptor used in studies of Oxidative Stress Response and Hormone Signaling. It is especially relevant in cancer, endocrinology, and infectious disease models, where defined compound exposure can be linked to redox signaling, ROS handling, and antioxidant defenses and ligand-dependent transcriptional programs and endocrine regulation.

By activating Estrogen/Progesterone Receptors and Estrogen Receptor, Psoralidin can be used to examine redox signaling, ROS handling, and antioxidant defenses and ligand-dependent transcriptional programs and endocrine regulation. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In cancer, endocrinology, and infectious disease models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Estrogen/Progesterone Receptors and Estrogen Receptor
• Pathway perturbation studies connected to Oxidative Stress Response and Hormone Signaling
• Agonist-response and downstream signaling studies
• Reporter-gene, receptor-binding, and transcriptional assays

Overall, Psoralidin is appropriate when a defined chemical perturbant is needed to connect Estrogen/Progesterone Receptors and Estrogen Receptor with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, endocrinology, and infectious disease models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.